ROCKVILLE, Md., June 9, 2021 /PRNewswire/ -- REGENXBIO Inc.
(Nasdaq: RGNX) today announced it will participate in the following
June investor conferences, which will each be held in a virtual
meeting format:
Bank of America 2021 Napa Biopharma Virtual
Conference
Fireside Chat: Wednesday,
June 16, 2021 at 12:30 p.m.
E.T.
Raymond James Human Health Innovation Conference
Date:
Monday, June 21, 2021
A live webcast of the Bank of America fireside chat can be
accessed in the 'Investors' section of REGENXBIO's website at
www.regenxbio.com. An archived replay of the webcast will be
available on the same website for approximately 30 days following
the fireside chat.
About REGENXBIO Inc.
REGENXBIO is a leading clinical-stage biotechnology company
seeking to improve lives through the curative potential of gene
therapy. REGENXBIO's NAV® Technology Platform, a
proprietary adeno-associated virus (AAV) gene delivery platform,
consists of exclusive rights to more than 100 novel AAV vectors,
including AAV7, AAV8, AAV9 and AAVrh10. REGENXBIO and its
third-party NAV Technology Platform Licensees are applying the NAV
Technology Platform in the development of a broad pipeline of
candidates in multiple therapeutic areas.
Contacts:
Tricia Truehart
Investor Relations and Corporate Communications
347-926-7709
ttruehart@regenxbio.com
Investors:
Brendan Burns, 212-600-1902
brendan@argotpartners.com
Media:
David Rosen, 212-600-1902
david.rosen@argotpartners.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/regenxbio-to-participate-in-upcoming-investor-conferences-301308489.html
SOURCE REGENXBIO Inc.